NASDAQ:CODX 27 October 2025

Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics Stock Surges on Ebola Test Push, But One Filing Shows the Catch

Co-Diagnostics shares jumped in heavy Nasdaq trading on Tuesday after the molecular-testing company said it had advanced a polymerase chain reaction, or PCR, assay strategy for the Bundibugyo strain behind a fast-moving Ebola outbreak in central Africa. PCR tests look for genetic material from a pathogen, often giving laboratories a way to confirm infection.

26 May 2026

NASDAQ:CODX·Stock Market

Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics shares slipped in premarket trading on Wednesday. The company said late Tuesday it had raised $3 million in a private placement, shortly after the stock surged 43.8% to finish at $1.97. The shares were down 13.3% to $1.71 in extended trading ahead of the regular Nasdaq open.

20 May 2026

Biotechnology·NASDAQ:CODX·Stock Market

Co-Diagnostics Stock Surges on Ebola Assay News — The Fine Print Is Big

Co-Diagnostics Inc. shares jumped in heavy U.S. trading on Tuesday after the molecular diagnostics company said it had completed a strategy for a possible Ebola assay tied to the Bundibugyo virus outbreak in the Democratic Republic of Congo and Uganda. The stock was recently up 51% at $2.07, after touching $2.73, on volume above 94 million shares; the iShares Russell 2000 exchange-traded fund, a small-cap stock basket, was down about 1.2%.

19 May 2026

Biotechnology·Health News·NASDAQ:CODX·Stock Market

Co-Diagnostics (CODX) Stock Triples on Saudi JV Deal – Analysts See More Upside Ahead

Co-Diagnostics stock exploded higher on Monday, triggered by an unexpected international deal. The small-cap diagnostics firm’s shares opened around $0.59 and skyrocketed, at one point up 133% by mid-morning ts2.tech. The rally accelerated throughout the day – by late morning CODX was +148% and still climbing amid wave after wave of retail buying ts2.tech. The stock ultimately closed at $1.07, up 206% in a single session ts2.tech. For context, CODX had ended the prior trading day around $0.35 and had been languishing at depressed levels after a year-long decline ts2.tech.

28 October 2025

Investment Opportunities·NASDAQ:CODX·Stock Market

Co-Diagnostics (CODX) Stock Skyrockets 200% on Saudi JV – Is This Just the Beginning?

Co-Diagnostics’ stock price erupted on Monday after the company unveiled a strategic joint venture in the Middle East. Shares of the small-cap diagnostics firm opened around $0.59 and quickly soared, at one point up 133% to about $0.82 by mid-morningbenzinga.com. The surge only intensified as trading progressed – by late morning the stock was up 148% and still climbing, prompting a wave of retail trader excitement onlinemenafn.com. CODX ultimately closed at $1.07, marking a stunning +206% one-day gainfinance.yahoo.com. For context, the stock had ended the prior trading day at roughly $0.35nasdaq.com, and was down over 70% in the past year before this week’s newstickernerd.com.

27 October 2025